211 related articles for article (PubMed ID: 20158911)
1. Generation and characterization of a Tet-On (rtTA-M2) transgenic rat.
Sheng Y; Lin CC; Yue J; Sukhwani M; Shuttleworth JJ; Chu T; Orwig KE
BMC Dev Biol; 2010 Feb; 10():17. PubMed ID: 20158911
[TBL] [Abstract][Full Text] [Related]
2. Use of a new-generation reverse tetracycline transactivator system for quantitative control of conditional gene expression in the murine lung.
Duerr J; Gruner M; Schubert SC; Haberkorn U; Bujard H; Mall MA
Am J Respir Cell Mol Biol; 2011 Feb; 44(2):244-54. PubMed ID: 20395635
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of a transgenic zebrafish expressing the reverse tetracycline transactivator.
Gu Q; Yang X; He X; Li Q; Cui Z
J Genet Genomics; 2013 Oct; 40(10):523-31. PubMed ID: 24156918
[TBL] [Abstract][Full Text] [Related]
4. Development of an all-in-one lentiviral vector system based on the original TetR for the easy generation of Tet-ON cell lines.
Benabdellah K; Cobo M; Muñoz P; Toscano MG; Martin F
PLoS One; 2011; 6(8):e23734. PubMed ID: 21876765
[TBL] [Abstract][Full Text] [Related]
5. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
[TBL] [Abstract][Full Text] [Related]
6. A Sox10(rtTA/+) Mouse Line Allows for Inducible Gene Expression in the Auditory and Balance Organs of the Inner Ear.
Walters BJ; Zuo J
J Assoc Res Otolaryngol; 2015 Jun; 16(3):331-45. PubMed ID: 25895579
[TBL] [Abstract][Full Text] [Related]
7. Generation of
Li YS; Meng RR; Chen X; Shang CL; Li HB; Zhang TJ; Long HY; Li HQ; Wang YJ; Wang FC
G3 (Bethesda); 2019 Feb; 9(2):591-599. PubMed ID: 30591434
[TBL] [Abstract][Full Text] [Related]
8. A Hoxb13-driven reverse tetracycline transactivator system for conditional gene expression in the prostate.
Rao V; Heard JC; Ghaffari H; Wali A; Mutton LN; Bieberich CJ
Prostate; 2012 Jul; 72(10):1045-51. PubMed ID: 22297979
[TBL] [Abstract][Full Text] [Related]
9. A system for inducible gene expression in retinal ganglion cells.
Kerrison JB; Duh EJ; Yu Y; Otteson DC; Zack DJ
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2932-9. PubMed ID: 16043868
[TBL] [Abstract][Full Text] [Related]
10. Development of a doxycycline-inducible lentiviral plasmid with an instant regulatory feature.
Yang T; Burrows C; Park JH
Plasmid; 2014 Mar; 72():29-35. PubMed ID: 24727543
[TBL] [Abstract][Full Text] [Related]
11. Combining fibroblast isolation with lentiviral gene transfer to validate transgene expression in mice following pronucleus injection.
Rössler OG; Lesch A; Thiel G
Transgenic Res; 2016 Dec; 25(6):839-846. PubMed ID: 27506594
[TBL] [Abstract][Full Text] [Related]
12. Expression of the reverse tetracycline-transactivator gene causes emphysema-like changes in mice.
Sisson TH; Hansen JM; Shah M; Hanson KE; Du M; Ling T; Simon RH; Christensen PJ
Am J Respir Cell Mol Biol; 2006 May; 34(5):552-60. PubMed ID: 16415250
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an immune-evading doxycycline-inducible lentiviral vector for gene therapy in the spinal cord.
De Winter F; Quijorna IF; Burnside E; Hobo B; Eggers R; Hoyng SA; Mulder HP; Hoeben RC; Muir EM; Bradbury EJ; Verhaagen J
Exp Neurol; 2022 Sep; 355():114120. PubMed ID: 35605669
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Screen to Identify Silent but Activatable (S/A) Integration Sites for a Tetracycline-Inducible Transgene in Mice.
Behringer R; Gertsenstein M; Nagy KV; Nagy A
Cold Spring Harb Protoc; 2018 Dec; 2018(12):. PubMed ID: 30510124
[TBL] [Abstract][Full Text] [Related]
15. Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter.
Markusic D; Oude-Elferink R; Das AT; Berkhout B; Seppen J
Nucleic Acids Res; 2005 Apr; 33(6):e63. PubMed ID: 15809225
[TBL] [Abstract][Full Text] [Related]
16. Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice.
Zhu Z; Ma B; Homer RJ; Zheng T; Elias JA
J Biol Chem; 2001 Jul; 276(27):25222-9. PubMed ID: 11331286
[TBL] [Abstract][Full Text] [Related]
17. Variability of inducible expression across the hematopoietic system of tetracycline transactivator transgenic mice.
Takiguchi M; Dow LE; Prier JE; Carmichael CL; Kile BT; Turner SJ; Lowe SW; Huang DC; Dickins RA
PLoS One; 2013; 8(1):e54009. PubMed ID: 23326559
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human factor IX expression using doxycycline-inducible gene expression system.
Srour MA; Fechner H; Wang X; Siemetzki U; Albert T; Oldenburg J; Hanfland P; Poller W; Brackmann HH; Schwaab R
Thromb Haemost; 2003 Sep; 90(3):398-405. PubMed ID: 12958607
[TBL] [Abstract][Full Text] [Related]
19. HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system.
Ginhoux F; Turbant S; Gross DA; Poupiot J; Marais T; Lone Y; Lemonnier FA; Firat H; Perez N; Danos O; Davoust J
Mol Ther; 2004 Aug; 10(2):279-89. PubMed ID: 15294175
[TBL] [Abstract][Full Text] [Related]
20. Generation of the regulatory protein rtTA transgenic mice.
Xu K; Deng XY; Yue Y; Guo ZM; Huang B; Hong X; Xiao D; Chen XG
World J Gastroenterol; 2005 May; 11(19):2885-91. PubMed ID: 15902723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
